|
2012 International Microbicides Conference Planning Committee
|
Meeting/ Workshop
|
CDC, FDA
|
OD/DPCPSI/OAR, NIAID, NICHD, NIMH, OD
|
Co-sponser and member of Scientific Program Committee for this international microbicides scientific conference, which is held every 2 years.
|
|
4th Annual Dissemination and Implementation Research Conference
|
Meeting/ Workshop
|
AHRQ, CDC
|
NIDCR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD
|
Multiple NIH institutes and centers participate in planning and implementing an international conference to facilitate the exchange of scientific data related to the dissemination and implementation research. This conference brings together clinical researchers, health services researchers, third-party payers, policy-makers and others to tackle the challenges of moving evidence-based prevention and treatment into community settings in sustainable ways.
|
|
4th National Conference on Genomics and Public Health
|
Meeting/ Workshop
|
AHRQ, CDC, HRSA
|
OD, NCI, NHGRI, NICHD
|
This conference was held on December 8-10, 2010, and brought together multi-disciplinary professionals from national, state, and other organization to learn about the use of genetics and genomic tools to prevent chronic, pediatric, infectious, environmental, and occupational diseases and provide quality genetic services across the lifespan.
|
|
A Re-Emerging Challenge: New Opportunities for Dengue Research Collaboration
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
The meeting will provide a forum for exchange of current information on basic and applied dengue research, identify research gaps and priorities, and promote and stimulate research collaborations in the Americas.
|
|
Accelerating Therapies for Rare Diseases Workshop
|
Meeting/ Workshop
|
FDA
|
NINDS, OD
|
The 3-day workshop focused on FDA''s regulatory requirements and the clinical trial issues that are especially relevant to rare disease and orphan products research.
|
|
Action for Health in Diabetes (Look AHEAD)
|
Research Initiative
|
CDC, IHS
|
NIDDK, NHLBI
|
This study is a 16-center, randomized clinical trial investigating the long-term health consequences of weight loss. The Look AHEAD cohort comprises approximately 5,000 overweight or obese participants with type 2 diabetes, aged 45-76. Participants were randomized to one of two interventions: an intensive lifestyle intervention designed to produce and sustain weight loss over the long term or a diabetes support and education arm. Participants will be followed for a total of 11 to 13.5 years from randomization.
|
|
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study (ACCORDION) -- Health Related Quality of Life and Cost Effectiveness Substudies
|
Research Initiative
|
CDC
|
NHLBI, NIDDK
|
The ACCORD study was primarily composed of three clinical trials that tested treatment approaches to determine the best ways to decrease the high rate of major CVD events – heart attack, stroke, or death from CVD – among people with type 2 diabetes who are at especially high risk of having a CVD event, like a heart attack or stroke. ACCORDION (the ACCORD Follow-up Study) is a prospective, observational follow-up study of approximately 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. It is designed to further elucidate and clarify the long-term effects of the ACCORD treatment strategy and provide additional data on the long-term relationships among various cardiovascular and diabetic risk factors. ACCORD participants had type 2 diabetes and were at high risk for a CVD event. Those who agree to participate in ACCORDION will continue to be followed through clinic and phone visits for an average of 3.5 years in the period 2011 through 2014. Participants will be seen in 76 clinics across the United States and Canada. The CDC is contributing intellectually and financially to the Health Related Quality of Life and Cost Effectiveness substudies of the trial.
|
|
Ad Hoc Interagency Working Group on Climate Change and Human Health
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
NIEHS, FIC
|
Developed, wrote, published, and disseminated a white paper on Federal research needs on impacts of climate change, as well as mitigation and adaptation, on human health. Coordinated and participated in Congressional briefings on the paper.
|
|
Addiction Technology Transfer Center
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
NIDA initiated a historic partnership with the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA) to expedite the dissemination of NIDA’s research results into the addiction treatment field. Blending teams composed of NIDA researchers, community treatment providers and trainers from SAMHSA’s Addiction Technology Transfer Centers (ATTC) work closely together to create innovative Blending products. Based on recently tested NIDA research, the Blending Teams design user-friendly products for clinical practitioners to use during treatment. Completed products include training packages composed of informational manuals, PowerPoint presentations, videos, CDs, curricula and annotated bibliographies.
|
|
Adolescent Health Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDA, NICHD, NIMH, NIMHD
|
Interagency working group established in January 2010 within the Office of the Assistant Secretary for Health as a forum for HHS agencies to share updates on adolescent health activities and address cross-cutting issues.
|